Chemistry & biodiversity · 2026
Health Beneficial Chemo Diversity and Antioxidant Potential of Philonotis revoluta Bosch & Sande Lac (A-Moss).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Parihar Sheela, Deora G S, Agrawal Jagrati, Sarswati, Shekhawat Monika K, Deora Sandhya
Аннотация
The current study evaluated the phytochemical composition and antioxidant potential of Philonotis revoluta using methanolic, ethyl acetate, and n-hexane extracts through analytical techniques. Preliminary qualitative analysis revealed secondary metabolites such as flavonoids, phenols, terpenoids, glycosides, alkaloids, and saponins. UV-visible analysis supported the occurrence of compounds, and FTIR analysis confirmed the presence of diverse functional groups. GC-MS identified various bioactive compounds, including ergost-5-en-3-ol, stigmasta-5,22-dien-3-ol, and other secondary metabolites. Quantitative analysis showed that the methanol extract had the highest total phenolic (21.97 ± 0.06 mg GAE/g) and total flavonoid content (38.97 ± 0.04 mg QE/g) compared to the ethyl acetate and n-hexane extracts. Antioxidant assays (DPPH, ABTS, and FRAP) showed a solvent polarity-dependent effect, with methanol showing stronger scavenging activity (IC50 229 ± 1.036 µg/mL ABTS; 568 ± 3.963 µg/mL DPPH), followed by the ethyl acetate and hexane extracts, while ethyl acetate (41.42 ± 0.000 µg FeSO4 eq/mL) showed comparatively higher ferric-reducing power than methanol and hexane extracts. All extracts showed significant antioxidant activity (p < 0.05). The study suggested P. revoluta contains numerous biologically active phytochemicals with promising antioxidant activity; therefore, there remains scope for this study to explore the therapeutic potential for the development of new drugs.